按癌症类型划分的药物再利用试验：肺癌 - Suppr

Suppr

超能文献

Repurposed Drugs Trials by Cancer Type: Lung Cancer.

作者信息

Murray Joseph C, Levy Benjamin

出版信息

Cancer J. 2019 Mar/Apr;25(2):127-133. doi: 10.1097/PPO.0000000000000371.

DOI:10.1097/PPO.0000000000000371

PMID:30896535

Abstract

摘要

相似文献

Repurposed Drugs Trials by Cancer Type: Lung Cancer.

Cancer J. 2019 Mar/Apr;25(2):127-133. doi: 10.1097/PPO.0000000000000371.

Repurposed Drugs for Prostate Cancer.

Cancer J. 2019 Mar/Apr;25(2):121-126. doi: 10.1097/PPO.0000000000000362.

Repurposed Drugs in Treating Glioblastoma Multiforme: Clinical Trials Update.

Cancer J. 2019 Mar/Apr;25(2):139-146. doi: 10.1097/PPO.0000000000000365.

The potential to treat lung cancer via inhalation of repurposed drugs.

Adv Drug Deliv Rev. 2018 Aug;133:107-130. doi: 10.1016/j.addr.2018.08.012. Epub 2018 Sep 4.

Introduction: Repurposed Drugs: Teaching an Old Dog New Tricks.

Cancer J. 2019 Mar/Apr;25(2):81. doi: 10.1097/PPO.0000000000000367.

Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An Update.

Cancer J. 2019 Mar/Apr;25(2):134-138. doi: 10.1097/PPO.0000000000000372.

The curious case of repurposed remedies: Researchers are finding surprising success in reusing old agents as new cancer therapies.

Cancer Cytopathol. 2018 Aug;126(8):509-510. doi: 10.1002/cncy.22043.

Computational Drug Repositioning with Random Walk on a Heterogeneous Network.

IEEE/ACM Trans Comput Biol Bioinform. 2019 Nov-Dec;16(6):1890-1900. doi: 10.1109/TCBB.2018.2832078. Epub 2018 May 2.

Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery Outcomes.

Cancer J. 2019 Mar/Apr;25(2):100-105. doi: 10.1097/PPO.0000000000000361.

Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.

Biochem Biophys Res Commun. 2016 Apr 1;472(2):299-305. doi: 10.1016/j.bbrc.2016.02.120. Epub 2016 Mar 2.

引用本文的文献

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?

Cancers (Basel). 2021 Jun 26;13(13):3193. doi: 10.3390/cancers13133193.

Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.

Med Sci Monit. 2020 Aug 17;26:e927106. doi: 10.12659/MSM.927106.

Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Semin Cancer Biol. 2021 Jan;68:209-229. doi: 10.1016/j.semcancer.2020.02.003. Epub 2020 Feb 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Repurposed Drugs Trials by Cancer Type: Lung Cancer.

Cancer J. 2019 Mar/Apr;25(2):127-133. doi: 10.1097/PPO.0000000000000371.

Repurposed Drugs for Prostate Cancer.

Cancer J. 2019 Mar/Apr;25(2):121-126. doi: 10.1097/PPO.0000000000000362.

Repurposed Drugs in Treating Glioblastoma Multiforme: Clinical Trials Update.

Cancer J. 2019 Mar/Apr;25(2):139-146. doi: 10.1097/PPO.0000000000000365.

The potential to treat lung cancer via inhalation of repurposed drugs.

Adv Drug Deliv Rev. 2018 Aug;133:107-130. doi: 10.1016/j.addr.2018.08.012. Epub 2018 Sep 4.

Introduction: Repurposed Drugs: Teaching an Old Dog New Tricks.

Cancer J. 2019 Mar/Apr;25(2):81. doi: 10.1097/PPO.0000000000000367.

Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An Update.

Cancer J. 2019 Mar/Apr;25(2):134-138. doi: 10.1097/PPO.0000000000000372.

The curious case of repurposed remedies: Researchers are finding surprising success in reusing old agents as new cancer therapies.

Cancer Cytopathol. 2018 Aug;126(8):509-510. doi: 10.1002/cncy.22043.

Computational Drug Repositioning with Random Walk on a Heterogeneous Network.

IEEE/ACM Trans Comput Biol Bioinform. 2019 Nov-Dec;16(6):1890-1900. doi: 10.1109/TCBB.2018.2832078. Epub 2018 May 2.

Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery Outcomes.

Cancer J. 2019 Mar/Apr;25(2):100-105. doi: 10.1097/PPO.0000000000000361.

Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.

Biochem Biophys Res Commun. 2016 Apr 1;472(2):299-305. doi: 10.1016/j.bbrc.2016.02.120. Epub 2016 Mar 2.

引用本文的文献

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?

Cancers (Basel). 2021 Jun 26;13(13):3193. doi: 10.3390/cancers13133193.

Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.

Med Sci Monit. 2020 Aug 17;26:e927106. doi: 10.12659/MSM.927106.

Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Semin Cancer Biol. 2021 Jan;68:209-229. doi: 10.1016/j.semcancer.2020.02.003. Epub 2020 Feb 7.